Go Pro
NASDAQ:XRTX

XORTX Therapeutics Q1 2025 Earnings Report

XORTX Therapeutics logo
$2.44 +0.22 (+9.91%)
Closing price 08/27/2026 03:59 PM Eastern
Extended Trading
$2.38 -0.06 (-2.25%)
As of 08/27/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

XORTX Therapeutics EPS Results

Actual EPS
-$0.95
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

XORTX Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

XORTX Therapeutics Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Thursday, May 15, 2025
Conference Call Time
6:00PM ET

Upcoming Earnings

XORTX Therapeutics' Q3 2026 earnings is estimated for Thursday, November 12, 2026, based on past reporting schedules, with a conference call scheduled at 6:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

XORTX Therapeutics Earnings Headlines

XORTX Therapeutics Inc.
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.tc pixel
XORTX Therapeutics Inc.: XORTX Announces Director Resignation
XORTX Announces Director Resignation
See More XORTX Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like XORTX Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on XORTX Therapeutics and other key companies, straight to your email.

About XORTX Therapeutics

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.

View XORTX Therapeutics Profile